Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Twenty-one malaria-naive volunteers were immunized with a vaccine consisting of a 22-kDa recombinant peptide (R32LR), derived from the repeat region of Plasmodium falciparum circumsporozoite (CS) protein, covalently coupled to detoxified Pseudomonas aeruginosa toxin A. Nineteen volunteers received a...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Infect Immun
Egile Nagusiak:	Fries, L F, Gordon, D M, Schneider, I, Beier, J C, Long, G W, Gross, M, Que, J U, Cryz, S J, Sadoff, J C
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1992
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC257081/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1563771/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.60.5.1834-1839.1992
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Antzeko izenburuak